SeaSpine Holdings Corp

SeaSpine Holdings Corp

  • Price (USD)10.44
  • Today's Change-0.05 / -0.48%
  • Shares traded77.96k
  • 1 Year change-18.37%
  • Beta0.9367
Data delayed at least 15 minutes, as of Jul 02 2020 21:00 BST.
More ▼

Profile data is unavailable for this security.

About the company

SeaSpine Holdings Corporation is a medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Company offers a portfolio of orthobiologics and spinal implants solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine. Its spinal implants portfolio consists of a line of products to facilitate spinal fusion in degenerative, minimally invasive surgery (MIS), and complex spinal deformity procedures. Orthobiologics products are used in orthopedic and dental procedures and consist of a range of bone graft substitutes to address the key elements of bone regeneration -osteoinduction, osteoconduction and osteogenesis. Spinal implant portfolio consists of a line of products for spinal decompression alignment and stabilization.

  • Revenue in USD (TTM)159.04m
  • Net income in USD-42.84m
  • Incorporated2015
  • Employees386.00
  • Location
    SeaSpine Holdings Corp5770 Armada DrCARLSBAD 92008-4608United StatesUSA
  • Phone+1 (760) 727-8399
  • Fax+1 (302) 636-5454
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
BioSig Technologies Inc0.00-39.54m215.57m33.00--12.64-----1.76-1.760.000.59390.00----0.00-278.13-545.48-311.66-2,346.95--------9.95--0.00-------59.73--135.80--
RTI Surgical Holdings Inc312.37m-220.42m219.33m935.00--12.57--0.7021-2.93-2.933.941.130.64491.155.65334,084.50-45.50-11.26-66.99-14.2355.5751.68-70.56-14.370.2714-0.78380.6768--9.803.25-5,164.73--0.1455--
Invacare Corporation922.99m-38.71m222.01m3.90k--0.73--0.2405-1.15-1.1527.368.841.045.307.93236,662.80-4.36-5.33-6.02-7.0828.5627.60-4.19-4.850.87040.28180.4723---4.56-6.09-16.07---2.480.00
iCAD Inc31.12m-21.65m224.42m135.00--13.83--7.21-1.11-1.111.630.71010.87633.444.29230,503.70-60.96-27.53-102.79-41.2775.3771.72-69.56-39.401.65-0.77210.3159--22.32-6.53-50.28---24.70--
Misonix Inc58.52m-11.23m231.43m125.00--1.50--3.95-0.7852-0.78524.248.900.49041.815.84468,197.60-9.41-8.00-10.27-9.4170.1669.95-19.18-7.634.00-8.090.2059--5.9117.89-22.14--56.67--
Alpha Pro Tech, Ltd.52.52m7.12m233.40m112.0032.645.7730.004.440.52670.52673.972.981.162.957.21--15.727.3618.257.8639.4637.2513.575.912.94--0.00--0.0879-0.4165-17.241.816.48--
Pulse Biosciences Inc0.00-48.77m264.06m82.00--10.07-----2.35-2.350.001.040.00----0.00-102.35-64.09-109.84-67.37------------0.00-------25.11--67.44--
SeaSpine Holdings Corp159.04m-42.84m284.43m386.00--1.50--1.79-2.07-2.077.626.970.81071.257.81412,031.10-21.84-29.80-25.61-36.3263.4059.44-26.93-32.994.30--0.00--10.902.78-17.16--27.53--
Iradimed Corp38.76m9.55m288.72m114.0030.894.9426.857.450.77560.77563.154.850.63132.136.93339,974.5015.5615.4516.9317.0676.8278.4824.6520.2711.54--0.000.0026.5419.7352.7936.26-4.33--
Semler Scientific Inc35.44m15.90m295.34m67.0022.8318.6717.848.331.981.984.432.422.47--17.23528,895.50110.8624.30144.6772.5989.8083.1944.889.28----0.00--52.4755.23200.84--30.95--
Stereotaxis Inc27.65m-5.86m312.61m118.00--13.76--11.31-0.089-0.0890.42180.39520.86482.535.61234,312.90-13.89-22.38-22.42--79.4774.52-16.06-14.452.87--0.00---1.51-3.76-357.07---24.96--
Alphatec Holdings Inc118.99m-64.71m314.63m227.00--11.44--2.64-1.14-,171.80-47.36-40.42-62.40-65.9268.9666.47-54.38-51.261.41-5.350.5139--23.70-6.01-34.53--2.89--
Utah Medical Products, Inc.47.07m14.46m314.63m182.0022.313.3314.536.683.873.9412.6025.920.45212.4410.10258,642.9013.8915.4114.6516.2962.7361.9930.7232.5711.70--0.0029.1311.682.59-5.644.9180.251.92
Oxford Immunotec Global PLC72.83m-5.05m339.37m243.00--1.71--4.66-0.1947-0.24342.747.630.31641.796.23299,720.20-2.20-6.11-2.36-6.8974.3766.23-6.94-15.6813.53--0.0002--23.368.29-110.72---11.27--
Viewray Inc81.75m-114.37m344.91m309.00--1.78--4.22-1.02-1.020.71271.320.26881.273.34264,556.60-37.60-50.36-46.73-72.33-2.72-0.1385-139.91-154.793.79-49.980.2227--8.4268.83-51.91--31.30--
Fulgent Genetics Inc34.91m-459.00k351.72m139.00--4.32144.8010.07-0.0131-0.01311.753.750.4816--6.30251,158.300.3973-7.550.4236-7.9856.4755.060.825-16.57----0.00--52.3591.0592.67--10.09--
Data as of Jul 02 2020. Currency figures normalised to SeaSpine Holdings Corp's reporting currency: US Dollar USD

Institutional shareholders

46.01%Per cent of shares held by top holders
HolderShares% Held
First Light Asset Management LLCas of 31 Mar 20204.49m16.48%
BlackRock Fund Advisorsas of 31 Mar 20201.41m5.16%
Driehaus Capital Management LLCas of 31 Mar 20201.37m5.03%
The Vanguard Group, Inc.as of 31 Mar 20201.03m3.79%
Polar Asset Management Partners, Inc.as of 31 Mar 2020969.09k3.56%
Hawk Ridge Capital Management LPas of 31 Mar 2020696.82k2.56%
Dimensional Fund Advisors LPas of 31 Mar 2020680.79k2.50%
Renaissance Technologies LLCas of 31 Mar 2020652.00k2.39%
Altrinsic Global Advisors LLCas of 31 Mar 2020627.27k2.30%
Altrinsic Global Advisors Canada, Inc.as of 28 Jun 2019607.65k2.23%
More ▼
Data from 28 Jun 2019 - 31 Mar 2020Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.